Oncogene - Table of Contents alert Volume 36 Issue 8

If you are unable to see the message below, click here to view.

Advertisement Specific CRISPR/Cas9/Cpf1 antibodies for clean and reliable results Validated for chromatin immunoprecipiation, IP, IF, Western blots  Available from S. pyogenes and S. aureus raised against the N- or C-terminus Polyclonal and monoclonal Learn more about our large collection of verified Cas9 and Cpf1 antibodies  TABLE OF CONTENTS Volume 36, Issue 8 (February 2017) In this issue Original Articles Corrigendum Also new AOP Advertisement   Open for Submissions   npj Precision Oncology is a new open access, online-only, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine. The journal is part of the Nature Partner Journals series and published in partnership with The Hormel Institute, University of Minnesota. Explore the benefits of submitting your manuscript. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. Explore the benefits of submitting your next research article. Original Articles Top miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation G Yang, Y Gong, Q Wang, L Wang and X Zhang Oncogene 2017 36: 1023-1037; advance online publication, August 15, 2016; 10.1038/onc.2016.270 Abstract | Full Text DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia Y Hu, H Su, C Liu, Z Wang, L Huang, Q Wang, S Liu, S Chen, J Zhou, P Li, Z Chen, H Liu and G Qing Oncogene 2017 36: 1038-1047; advance online publication, September 5, 2016; 10.1038/onc.2016.275 Abstract | Full Text Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer J Izrailit, A Jaiswal, W Zheng, M F Moran and M Reedijk Oncogene 2017 36: 1048-1057; advance online publication, September 5, 2016; 10.1038/onc.2016.276 Abstract | Full Text Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors OPEN D H Ki, S He, S Rodig and A T Look Oncogene 2017 36: 1058-1068; advance online publication, August 1, 2016; 10.1038/onc.2016.269 Abstract | Full Text Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression Y Pan, S Wang, B Su, F Zhou, R Zhang, T Xu, R Zhang, V Leventaki, E Drakos, W Liu and F X Claret Oncogene 2017 36: 1069-1079; advance online publication, August 15, 2016; 10.1038/onc.2016.271 Abstract | Full Text Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma J M Thompson, Q H Nguyen, M Singh, M W Pavesic, I Nesterenko, L J Nelson, A C Liao and O V Razorenova Oncogene 2017 36: 1080-1089; advance online publication, November 14, 2016; 10.1038/onc.2016.272 Abstract | Full Text Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells Y Deng, J Cheng, B Fu, W Liu, G Chen, Q Zhang and Y Yang Oncogene 2017 36: 1090-1101; advance online publication, September 5, 2016; 10.1038/onc.2016.273 Abstract | Full Text RCP induces Slug expression and cancer cell invasion by stabilizing β1 integrin M H Hwang, K H Cho, K J Jeong, Y-Y Park, J M Kim, S-L Yu, C G Park, G B Mills and H Y Lee Oncogene 2017 36: 1102-1111; advance online publication, August 15, 2016; 10.1038/onc.2016.277 Abstract | Full Text The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma C Cao, T Zhang, D Zhang, L Xie, X Zou, L Lei, D Wu and L Liu Oncogene 2017 36: 1112-1122; advance online publication, August 15, 2016; 10.1038/onc.2016.278 Abstract | Full Text Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3′ splice sites within RNA secondary structures A K Kesarwani, O Ramirez, A K Gupta, X Yang, T Murthy, A C Minella and M M Pillai Oncogene 2017 36: 1123-1133; advance online publication, August 15, 2016; 10.1038/onc.2016.279 Abstract | Full Text CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR J Hou, Q Deng, J Zhou, J Zou, Y Zhang, P Tan, W Zhang and H Cui Oncogene 2017 36: 1134-1144; advance online publication, August 22, 2016; 10.1038/onc.2016.280 Abstract | Full Text UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy L Hu, X Li, Q liu, J Xu, H Ge, Z Wang, H Wang, Z Wang, C Shi, X Xu, J Huang, Z Lin, R O Pieper and C Weng Oncogene 2017 36: 1145-1156; advance online publication, September 5, 2016; 10.1038/onc.2016.281 Abstract | Full Text Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression Y Xu, L Qin, T Sun, H Wu, T He, Z Yang, Q Mo, L Liao and J Xu Oncogene 2017 36: 1157-1166; advance online publication, August 15, 2016; 10.1038/onc.2016.286 Abstract | Full Text Corrigendum Top Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells Y Suh, C-H Yoon, R-K Kim, E-J Lim, Y S Oh, S-G Hwang, S An, G Yoon, M C Gye, J-M Yi, M-J Kim and S-J Lee Oncogene 2017 36: 1167-1168; advance online publication, November 14, 2016; 10.1038/onc.2016.294 Full Text Advertisement An online-only, open access, multidisciplinary journal dedicated to publishing high-quality original research articles, reviews, editorials, commentaries, and hypothesis generating observations on all areas of breast cancer research. Part of the Nature Partner Journals series, published in partnership with the Breast Cancer Research Foundation. Now open for submissions >> Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.